SUPN Supernus Pharmaceuticals Inc

NASDAQ
$28.61

Supernus Pharmaceuticals Inc (SUPN) Seasonality

What this stock has historically done over the three months following this point in the calendar year, measured against every other three-month stretch on record.

The three months from November 21

From November, on average
+4.96%
64 matching years
Any three months
+5.43%
3,597 starting points
Difference
-0.5 pts
worse than usual

Both lines start at zero on day 0, so the vertical gap reads directly as percentage points better or worse than a random three months. A seasonal line sitting on top of the baseline is a real answer: it says the calendar tells you nothing here. Price history from May 2012 to November 2026.

Between earnings releases

The same study run on the earnings cycle rather than the calendar: the average move from one report to the next, broken out by fiscal quarter, with the announcement gap and the run-up separated out.

Sign in or subscribe to see it